Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atlantic cod
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
Atlantic cod is a lean fish (Gadus morhua) that has been investigated for its potential health benefits, particularly in individuals with overweight or obesity. Clinical trials have shown that a high intake of Atlantic cod (750 g/week) can reduce serum concentrations of total neopterin, a marker associated with cellular immune activation and cardiovascular disease. It has also been observed to increase serum selenium levels, an essential cofactor for antioxidant enzymes.
- Other names
- codwild-caught Gadus morhua
Beyond the preview
Go deeper on Atlantic cod.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atlantic cod.